Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
Frontiers | Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
Prognosis for p65 hyperactivation in diffuse large B-cell lymphoma... | Download Scientific Diagram
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Diffuse Large B cell lymphoma (DLBCL) - Lymphoma Australia
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients | Haematologica
New Approaches to the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma - an overview | ScienceDirect Topics
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy
Diffuse Large B-Cell Lymphoma | NEJM
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Diffuse large B-cell lymphoma symptoms, diagnosis and treatment - YouTube
The overall survival of in diffuse large B-cell lymphoma (DLBCL)... | Download Scientific Diagram
